- Home
- SIFY vs ACIU Comparison
SIFY vs ACIU Comparison
Compare SIFY & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIFY
- ACIU
- Stock Information
- Founded
- SIFY 1995
- ACIU 2003
- Country
- SIFY India
- ACIU Switzerland
- Employees
- SIFY N/A
- ACIU N/A
- Industry
- SIFY Computer Software: Programming Data Processing
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- SIFY Technology
- ACIU Health Care
- Exchange
- SIFY Nasdaq
- ACIU Nasdaq
- Market Cap
- SIFY 280.2M
- ACIU 305.7M
- IPO Year
- SIFY 1999
- ACIU 2016
- Fundamental
- Price
- SIFY $2.68
- ACIU $3.19
- Analyst Decision
- SIFY
- ACIU Strong Buy
- Analyst Count
- SIFY 0
- ACIU 2
- Target Price
- SIFY N/A
- ACIU $12.00
- AVG Volume (30 Days)
- SIFY 144.5K
- ACIU 140.1K
- Earning Date
- SIFY 10-22-2024
- ACIU 11-05-2024
- Dividend Yield
- SIFY N/A
- ACIU N/A
- EPS Growth
- SIFY N/A
- ACIU N/A
- EPS
- SIFY N/A
- ACIU N/A
- Revenue
- SIFY $443,027,157.00
- ACIU $48,505,404.00
- Revenue This Year
- SIFY N/A
- ACIU N/A
- Revenue Next Year
- SIFY $12.52
- ACIU $938.44
- P/E Ratio
- SIFY $49.92
- ACIU N/A
- Revenue Growth
- SIFY 5.85
- ACIU 4097200.00
- 52 Week Low
- SIFY $1.80
- ACIU $2.25
- 52 Week High
- SIFY $12.30
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- SIFY 39.04
- ACIU 50.14
- Support Level
- SIFY $2.61
- ACIU $2.80
- Resistance Level
- SIFY $3.18
- ACIU $3.88
- Average True Range (ATR)
- SIFY 0.22
- ACIU 0.22
- MACD
- SIFY -0.11
- ACIU 0.04
- Stochastic Oscillator
- SIFY 6.31
- ACIU 36.11
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.